Journal of Clinical & Experimental OncologyISSN: 2324-9110

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Rodriacute;guez-Cerdeira C Author

carmencerdeira33@gmail.com 34986814517

Subjects of specialization
Breast neoplasm, Cancer chemotherapy, Prostate biomarker, Endometrial cancer

Affiliation
Department of Dermatology, CHUVI & University of Vigo, Vigo, Spain

Biography

Rodriacute;guez-Cerdeira C was working in the Department of Dermatology, CHUVI & University of Vigo, Vigo, Spain. He has more than 40 publications. His current research area related to oncology. 

Publications

Case Report Subscription

Lack of Response to Vismodegib in a Patient with Advanced Basal Cell Carcinoma: A Case Report

Author(s):

Rodríguez-Cerdeira C and Munoz-Garzon V

Purpose: Basal cell carcinoma (BCC), the most common type of skin cancer in humans, rarely progresses to locally advanced or metastatic BCC. The size, extent, and location of the lesion should be carefully considered when selecting a treatment option for patients with BCC.

Methods: Moreover, clinicians should review the potential for significant deformity and anticipated morbidity, when considering radiation therapy and surgery for treatment. Vismodegib, the first approved oral therapy for advanced BCC, is a treatment option that clinicians might consider for patients with BCC lesions that exhibit the clinical characteristics as described above.

view more»

DOI: 10.4172/2324-9110.1000177

Abstract HTML PDF

Google Scholars / Researchers Sites

Explore SciTechnol

GET THE APP